50404 Investors following Cipla. Share this News with them.
0
Like this story, share it with millions of investors on M3
Avesthagen launches 7 botanical bioactives
Life-sciences company Avesthagen Ltd has launched seven botanical bioactives under the Avesta brandname targeting specific conditions like diabetes, bone-loss and cardiovascular-diseases, reports Business Line.
Life-sciences company Avesthagen Ltd has launched seven botanical bioactives under the Avesta brandname targeting specific conditions like diabetes, bone-loss and cardiovascular-diseases.
For starters, the branded bio-active ingredients will be used in food-products, even as human trials are underway to launch the ingredients as prescription, pharmaceutical products a year later, said Dr Villoo Morawala Patell, Chairperson and Managing Director of Avesthagen.
The bioactives, manufactured at the company's plant near Bangalore, will be sold through the fast-moving consumer goods channel, and the pharmacy channel, said Mr Samaresh Parida, Avesthagen's Chief Operating Officer.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Namma Metro | Tata Steel | Reliance Industries | Mahindra Satyam | Aurobindo Pharma | BSE Sensex | Montek Singh Ahluwalia | Iran | Vodafone Essar 
For starters, the branded bio-active ingredients will be used in food-products, even as human trials are underway to launch the ingredients as prescription, pharmaceutical products a year later, said Dr Villoo Morawala Patell, Chairperson and Managing Director of Avesthagen. 
